Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $121.8700 (0.4%) ($120.2800 - $122.7200) on Thu. Aug. 3, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.38% (three month average) | RSI | 63 | Latest Price | $121.8700(0.4%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND advances 1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -0.69% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.69% (StdDev 1.38%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $121.4(0.39%) | 10 Day Moving Average | $122.18(-0.25%) | 20 Day Moving Average | $120.51(1.13%) | To recent high | -1.6% | To recent low | 12.6% | Market Cap | $1.959b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |